Population reference ranges and determinants of plasma homocysteine levels

被引:0
作者
Zubizarreta, JIP
Garbizu, II
Errasti, CA
机构
[1] Hosp Cruces, Unidad Epidemiol Clin, Baracaldo 48903, Vizcaya, Spain
[2] Univ Basque Country, Dept Matemat Aplicada & Invest Operat, E-48080 Bilbao, Spain
[3] Univ Basque Country, Catedra Patol Med, Hosp Cruces, Med Interna Serv, E-48080 Bilbao, Spain
来源
MEDICINA CLINICA | 2001年 / 117卷 / 13期
关键词
homocysteine; reference values; regression analysis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: There is a well-known relationship between plasma homocysteine levels and the risk of cardiovascular events. Determination of homocysteine levels may also be of potential diagnostic aid in several clinical situations. The construction of reference ranges should take age and sex variations into account. SUBJECTS AND METHODS: 396 healthy subjects were recruited (172 males and 224 females). Fasting plasma homocysteine levels were measured using the fluorescein polarization immunoassay technique (FPIA). Plasma levels of creatinine, folates, vitamin B-12 and TSH were measured. 90% reference ranges were estimated by fractional polynomial regression methods. RESULTS: Homocysteine plasma levels ranged from 4.35 mu mol/l to 17.71 mu mol/l (median 8.62 mu mol/l). These concentrations increased with age and were higher in males (median 9.53 mu mol/l [range: 5.45-17.5]) than in females (median 7.79 mu mol/l [range: 4.35-17.71]). Sex differences decreased in the elderly. Creatinine plasma levels (with a positive association) and folate levels (with a negative association) had a statistically significant effect on the specific distribution of homocysteine levels according to age and sex. CONCLUSIONS: Age- and sex-specific reference ranges of plasma homocysteine have been defined. Renal function along with folate plasma levels have to be accounted for when assessing these distribution ranges.
引用
收藏
页码:487 / 491
页数:5
相关论文
共 30 条
[1]   Endpoints for homocysteine-lowering trials [J].
Bostom, AG ;
Garber, C .
LANCET, 2000, 355 (9203) :511-512
[2]   Homocysteine and arteriosclerosis - Subclinical and clinical disease associations [J].
Bostom, AG ;
Selhub, J .
CIRCULATION, 1999, 99 (18) :2361-2363
[3]  
Carmel R, 1999, AM J CLIN NUTR, V70, P904
[4]   Blood levels off homocysteine and increased risks of cardiovascular disease -: Causal of casual? [J].
Christen, WG ;
Ajani, UA ;
Glynn, RJ ;
Hennekens, CH .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :422-434
[5]   Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction [J].
Christensen, B ;
Landaas, S ;
Stensvold, I ;
Djurovic, S ;
Retterstol, L ;
Ringstad, J ;
Berg, K ;
Thelle, DS .
ATHEROSCLEROSIS, 1999, 147 (02) :317-326
[6]  
Clarke R, 1998, CLIN CHEM, V44, P102
[7]   An alternative view of homocysteine [J].
Dudman, NPB .
LANCET, 1999, 354 (9195) :2072-2074
[8]   Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence [J].
Eikelboom, JW ;
Lonn, E ;
Genest, J ;
Hankey, G ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :363-375
[9]   Influence of menopausal status in homocysteine plasma levels [J].
Fernández-Miranda, C ;
de la Calle, M ;
Bris, JM ;
Muelas, M ;
Gómez, P ;
Díaz-Rubio, P .
MEDICINA CLINICA, 2001, 116 (06) :206-208
[10]   Homocysteine and vascular disease [J].
Hankey, GJ ;
Eikelboom, JW .
LANCET, 1999, 354 (9176) :407-413